<DOC>
	<DOCNO>NCT00301353</DOCNO>
	<brief_summary>Osteoporosis major health problem . It hypothesize isoflavone-containing product may potential alternative HRT prevent bone loss menopausal transition . We investigate whether one-year consumption isoflavone-enriched food affect bone mineral density , bone metabolism hormonal status early postmenopausal woman randomize double-blind , placebo control parallel multi-centre trial .</brief_summary>
	<brief_title>Effects Phytoestrogen-rich Diets Bone Turnover Postmenopausal Women</brief_title>
	<detailed_description>Two hundred thirty-seven healthy early post-menopausal woman ( age 53 ± 3 ; time since last menses 33 ± 15 month ) consume isoflavone-enriched food provide mean daily intake 110 mg isoflavone aglycones control product 1 yr whilst continue habitual diet lifestyle . Outcome measure include bone mineral density lumbar spine total body , marker bone formation bone resorption , hormone , isoflavones plasma urine , safety parameter report adverse event .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Phytoestrogens</mesh_term>
	<criteria>1 . Healthy assess : health lifestyle questionnaire physical examination result prestudy laboratory test 2 . Caucasian woman 3 . Postmenopausal ( ≥12 ≤60 month since last menses ) , determine interview FSH level ≥ 20 IU/l 4 . Body Mass Index ( BMI ) ≥22 ≤29 kg/m2 5 . Voluntary participation 6 . Having give write informed consent 7 . Willing comply study procedures 8 . Willing accept use nameless data , include publication confidential use storage data 9 . Willing accept disclosure financial benefit participation study authority concern 1 . Participation clinical trial include blood sample and/or administration product 90 day Day 01 study 2 . Participation noninvasive clinical trial 30 day Day 01 study , include blood sample and/or oral , intravenous , inhalatory administration product 3 . Osteoporosis , determine Questionnaire ( spontaneous bone fracture , use medication treat osteoporosis ) DXA scan lumbar spine day 14 day 1 study ; exclusion threshold set 2z score BMD 4 . Severe scoliosis ( curvature spine ) could interfere ability subject go DXA scan procedure and/or correct read DXA scan 5 . Having history medical surgical event may significantly affect study outcome , include : surgical menopause ( include hysterectomy ) antecedent high familiar incidence breast and/or endometrial cancer gastrointestinal disease ( Crohn 's , short bowel syndrome , coeliac disease , gastroenteritis episode month start study ) hepatic disease ( acute viral hepatitis , chronic hepatitis ) cardiovascular disease thrombosis impair renal function severe immune disease endocrine disease ( hyperthyroidism , hyperparathyroidism , IDDM , NIDDM ) 6 . Food allergy report subject ( special emphasis soy product ) report allergy sunscreen product 7 . Use concomitant medication include Hormonal replacement therapy ( study within last 6 month day 01 study ) Current use corticosteroid ( include Aerosol therapy ) past use 10 day within last 6 month Osteoporosis treatment ( biphosphonates , SERM 's , calcitonin , injectable PTH ) Other medication know affect bone metabolism ( statin ) . Use antibiotic carefully record . 8 . Change smoke habit last 2 month 9 . Alcohol consumption &gt; 21 unit ( drink ) /week 10 . Reported unexplained weight loss gain &gt; 5 % usual body weight month prior prestudy screen 11 . Reported slimming medically prescribe diet 12 . Professional sportswoman ( &gt; 10 hour extensive sports/week ) 13 . Reported vegan , vegetarian , macrobiotic food intake 14 . Regular intake soy base food ( &gt; 2 serving per week ) . Participation possible subject prepare stop consumption screen end study 15 . Taking supplement contain isoflavones , 3 month prior enrolment study . Subjects start take calcium vitamin D supplement study . However , subject already take calcium vitamin D supplement maintain intake study 16 . Recent blood plasma donation ( &lt; 1 month prior start study ) 17 . Not willing stop blood plasma donation study 18 . TNO Nutrition Food Research personnel , partner first second generation relatives 19 . Not general practitioner 20 . Not willing accept informationtransfer concern participation study , information regard his/her health . For example , laboratory result , finding health lifestyle questionnaire interview , physical examination eventual adverse event communicate general practitioner 21 . Mental status incompatible proper conduct study</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2002</verification_date>
	<keyword>early menopause</keyword>
	<keyword>isoflavones/phyto-estrogens</keyword>
	<keyword>bone metabolism</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>hormone</keyword>
</DOC>